Pfizer and Hisun had signed a memorandum of understanding (MOU) in June 2011 for the establishment of the joint venture. Hisun-Pfizer, which has a registered capital of $250 million, has a total ...

TAIZHOU, ZHEJIANG PROVINCE, CHINA & VERO BEACH, FL / ACCESSWIRE / July 18, 2016 / Nascent Biotech, Inc. (NBIO), and Zhejiang Hisun Pharmaceutical Company Ltd., today announced they have entered into ...

SHANGHAI, China & NEW YORK, NY, USA I February 20, 2012 I Pfizer Inc. and Zhejiang Hisun Pharmaceutical, a leading pharmaceutical company in China, today signed a framework agreement, advancing their ...

China’s Zhejiang Hisun Pharmaceutical has gotten in progressively hotter water with the FDA but its troubles have not kept it from striking deals globally with other drugmakers, including one this ...

HONG KONG – China's Zhejiang Hisun Pharmaceutical Co. Ltd. said results of two key phase III trials for HS-25, a cholesterol absorption inhibitor that targets hyperlipoproteinemia, showed both met the ...

Somerset, N.J. & Taizhou City, Zhejiang Province, China — Catalent Pharma Solutions, the leading global provider of development solutions and advanced delivery technologies for drug, biologic and ...

SHANGHAI & NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Zhejiang Hisun Pharmaceuticals (SSE stock code 600267), a leading pharmaceutical company in China, today jointly announced the signing ...

Celsion Corporation has announced that it has signed a long-term Technology Transfer, Manufacturing and Commercial Supply Agreement with Zhejiang Hisun Pharmaceutical Co. Ltd. to pursue an expanded ...

TAIZHOU, China--(BUSINESS WIRE)--According to news on June 29 from Middle East News Agency, Favipiravir, the popular drug used for treating COVID-19 has shown excellent results in clinical tests. AP, ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...